Cargando…

MicroRNA-448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway

Detalles Bibliográficos
Autores principales:	Wu, Shen, Ai, Nanping, Liu, Qian, Zhang, Jingxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245075/ https://www.ncbi.nlm.nih.gov/pubmed/35730602 http://dx.doi.org/10.3892/or.2022.8351

Ejemplares similares

MicroRNA-936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
por: Xu, Lishuai, et al.
Publicado: (2022)

Retracted: Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
por: Healthcare Engineering, Journal of
Publicado: (2023)

MicroRNA-766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway
por: Zhao, Jianjie, et al.
Publicado: (2022)

Retraction: MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7
Publicado: (2023)

Retraction: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway
Publicado: (2020)

MicroRNA-874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin
por: Zhang, Yongfeng, et al.
Publicado: (2022)

MicroRNA-511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway
por: Zhao, Yuying, et al.
Publicado: (2022)

MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway
por: Yu, Dan-Li, et al.
Publicado: (2022)

microRNA-485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a
por: Lyu, Xueman, et al.
Publicado: (2022)

Downregulation of microRNA-198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN
por: Wei, Dongdong, et al.
Publicado: (2022)

microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction]
Publicado: (2021)

MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis [Retraction]
Publicado: (2023)

microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction]
Publicado: (2021)

MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway
por: Zhao, Xiwu, et al.
Publicado: (2022)

MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction]
Publicado: (2021)

MicroRNA-936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
por: Xu, Lishuai, et al.
Publicado: (2020)

MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways
por: Liu, Xuerong, et al.
Publicado: (2022)

[Retracted] MicroRNA‑1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling
por: Liu, Chao, et al.
Publicado: (2023)

Retraction: MicroRNA-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway
Publicado: (2021)

MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction]
Publicado: (2021)

MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling
por: Si, Fengzhi, et al.
Publicado: (2021)

microRNA-877 Inhibits Malignant Progression of Colorectal Cancer by Directly Targeting MTDH and Regulating the PTEN/Akt Pathway [Retraction]
Publicado: (2021)

MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer
por: Xia, Huan, et al.
Publicado: (2021)

MicroRNA-21 increases cell viability and suppresses cellular apoptosis in non-small cell lung cancer by regulating the PI3K/Akt signaling pathway
por: Wang, Tao, et al.
Publicado: (2021)

Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway
por: Engineering, Journal of Healthcare
Publicado: (2023)

MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction]
Publicado: (2021)

microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1
por: Lei, Pengfei, et al.
Publicado: (2022)

MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways
por: Zhang, Min, et al.
Publicado: (2022)

Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma
por: Markers, Disease
Publicado: (2023)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

MicroRNA-448 modulates the progression of neuropathic pain by targeting sirtuin 1
por: Chu, Yunchao, et al.
Publicado: (2019)

MicroRNA-197 inhibits gastric cancer progression by directly targeting metadherin
por: Liao, Zhiwei, et al.
Publicado: (2022)

Retraction statement: MicroRNA‐21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway
Publicado: (2021)

Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway
por: Markers, Disease
Publicado: (2023)

[Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways
por: Kang, Kang, et al.
Publicado: (2023)

MicroRNA-497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3
por: Zhuang, Juhua, et al.
Publicado: (2022)

Retracted: CaMKK2 Promotes the Progression of Ovarian Carcinoma through the PI3K/PDK1/Akt Axis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
por: Fu, Xiao, et al.
Publicado: (2023)

Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA-124 and thereby upregulating STAT3
por: Sun, Xiaowen, et al.
Publicado: (2022)

Retracted: MicroRNA-1179 regulates proliferation and chemosensitivity of human ovarian cancer cells by targeting the PTEN-mediated PI3K/AKT signaling pathway
por: Zhihong, Zhang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rgb8oltaeaakv33ngdjufa838b